Raquel Buj

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Oxide Nanoparticles

Top Venues

Cancer research communications

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Kelly E Leon, Naveen Kumar Tangudu, Katherine M Aird, Raquel Buj
Loss of p16: A Bouncer of the Immunological Surveillance? Life (Basel, Switzerland) 11 (4) (2021)